Comparing the cumulative incidences of add-on therapy among the major antihypertensive classes in 2531 Asian patients: A cohort study

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 2, 2010, Pages 201-205

  Wong, M C S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Add on therapy; Antihypertensive drugs; Asian patients; Efficacy; Ethnic difference; Prescription choice

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADD ON THERAPY; ADULT; ARTICLE; ASIAN; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES MELLITUS; ETHNICITY; FEMALE; GENDER; GOUT; HONG KONG; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT DEPARTMENT; PRIMARY MEDICAL CARE; SEX DIFFERENCE; STROKE;

ADULT; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SEX FACTORS;

EID: 77749304166     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01076.x     Document Type: Article

References (13)

1. Neaton JD, Grimm RH Jr., Prineas RJ et al. (1993) Treatment of mild hypertension study (TOMHS). JAMA: The Journal of the American Medical Association, 270, 713 724.
2. Wright JM, Lee CH, Chambers GK (1999) Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ: Canadian Medical Association Journal, 161, 25 32.
3. Staessen JA, Wang J-G, Thijs L (2003) Cardiovascular protection and blood pressure reduction: a quantitative overview updated until 1 March 2003. Journal of Hypertension, 21, 1055 1076.
4. Carlberg B, Samuelsson O, Lindholm LH (2004) Atenolol in hypertension: is it a wise choice? Lancet, 364, 1684 1689.
5. Chobanian AV, Bakris GL, Black HR et al. (2003) Seventh report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 42, 1206 1252.
6. Lenert LA, Linde-Zwirble W, Newbold R III., Korenblat BM, Doherty J, Smith ME (1999) Using administrative data to compare the relative effectiveness of amlodipine vs. nifedipine CC. American Journal of Managed Care, 5, 1535 1540.
7. Ambrosioni E, Leonetti G, Pessina AC et al. (2000) Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on antihypertensive therapy. Journal of Hypertension, 18, 1691 1699.
8. Dusing R, Weisser B, Mengden T, Vetter H (1998) Changes in antihypertensive therapy-the role of adverse effects and compliance. Blood Pressure, 7, 313 315.
9. Brown MJ (2006) Hypertension and ethnic group. British Medical Journal, 332, 833 836.
10. Cheung NT. Health informatics, Hospital Authority, Hong Kong. Realizing the benefits of eHealth in Hong Kong. Available at: http://www.ehealth.org.hk/ Speaker/Dr%20Ngai%20Tseung%20CHEUNG.pdf Accessed 12 September 2008.
11. Wong MCS, Jiang Y, Tang JL, Lam A, Fung H, Mercer SW (2008) Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Services Research, 8, 138.
12. Materson BJ, Reda DJ, Cushman WC (1995) Department of Veterans Affairs single-drug therapy of hypertension study. American Journal of Hypertension, 8, 189 192.
13. Cheung BMY, Law FCY, Tam SCF, Kumana CR, Lau CP (2002) Plasma rennin activity and aldosterone level in patients with essential hypertension. American Journal of Hypertension, 15, 210A.